- Report
- October 2023
- 186 Pages
Global
From €5258EUR$5,500USD£4,518GBP
- Report
- March 2024
- 194 Pages
Global
From €3226EUR$3,374USD£2,772GBP
€3584EUR$3,749USD£3,080GBP
- Report
- October 2023
- 75 Pages
Global
From €5688EUR$5,950USD£4,888GBP
- Report
- May 2023
- 169 Pages
Global
From €2247EUR$2,350USD£1,931GBP
- Report
- February 2024
- 175 Pages
Global
From €4780EUR$5,000USD£4,108GBP
- Report
- October 2023
- 185 Pages
Global
From €4684EUR$4,900USD£4,026GBP
- Report
- November 2023
- 177 Pages
Global
From €4684EUR$4,900USD£4,026GBP
- Report
- October 2023
- 190 Pages
Global
From €4684EUR$4,900USD£4,026GBP
- Report
- January 2024
- 200 Pages
Global
From €3967EUR$4,150USD£3,409GBP
- Report
- December 2023
Global
From €7170EUR$7,500USD£6,162GBP
- Report
- September 2023
- 124 Pages
North America
From €2580EUR$2,699USD£2,217GBP
- Report
- October 2023
- 78 Pages
United States
From €3346EUR$3,500USD£2,875GBP
- Report
- March 2024
- 95 Pages
Europe
From €1434EUR$1,500USD£1,232GBP
- Report
- March 2024
- 97 Pages
Middle East, Africa
From €1434EUR$1,500USD£1,232GBP
- Report
- February 2021
- 360 Pages
United States
From €2294EUR$2,400USD£1,972GBP
- Report
- August 2020
Global
From €5057EUR$5,290USD£4,346GBP
- Clinical Trials
- September 2021
- 60 Pages
Global
From €1912EUR$2,000USD£1,643GBP
- Report
- October 2023
- 88 Pages
India
From €3346EUR$3,500USD£2,875GBP
- Report
- April 2023
- 110 Pages
Global
From €4541EUR$4,750USD£3,902GBP
- Report
- January 2022
- 110 Pages
Global
From €4541EUR$4,750USD£3,902GBP
The antiretroviral market is a subset of the HIV/AIDS drugs market, which is focused on the development and sale of drugs that can be used to treat HIV/AIDS. Antiretroviral drugs are used to reduce the amount of HIV in the body, and can be used to prevent the transmission of HIV from one person to another. These drugs are typically used in combination with other treatments, such as counseling and lifestyle changes, to help people living with HIV/AIDS manage their condition.
The antiretroviral market is highly competitive, with many companies developing and selling drugs to treat HIV/AIDS. Some of the major players in the market include Gilead Sciences, Merck, Bristol-Myers Squibb, GlaxoSmithKline, and ViiV Healthcare. Other companies, such as AbbVie, Janssen, and Mylan, also have a presence in the market. Show Less Read more